|Bid||21.37 x 1000|
|Ask||22.00 x 3200|
|Day's range||20.25 - 22.49|
|52-week range||10.76 - 40.91|
|Beta (5Y monthly)||2.24|
|PE ratio (TTM)||N/A|
|Earnings date||16 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||28 Aug 1996|
|1y target est||19.00|
Blood clot concerns lack context, experts say, putting pressure on federal agencies to unpause J&J vaccinations.
CEL-SCI Corporation reports first quarter fiscal 2021 financial results.
Investors are betting that these three stocks could turn them into millionaires in incredibly short periods of time. Will they succeed?